Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free β‐hCG or PAPP‐A levels?
- 20 August 2001
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 21 (9) , 715-717
- https://doi.org/10.1002/pd.152
Abstract
In a study of 180 twin pregnancies I have examined the distribution of maternal serum free β-human chorionic gonadotrophin (β-hCG) and pregnancy-associated plasma protein-A (PAPP-A), in addition to fetal nuchal translucency thickness (NT), in twins classified as monochorionic or dichorionic, based on ultrasound appearance at 10–14 weeks of gestation. In 45 monochorionic and 135 dichorionic twin pregnancies the median MoM free β-hCG was not significantly different (1.00 vs 1.01), whilst that for PAPP-A was lower (0.89 vs 1.01) but again with no statistical significance. Previous reports of an increased fetal NT in monochorionic twins pregnancies could not be confirmed (1.03 vs 1.00). It is concluded that the existing pseudo risk twin correction algorithm is appropriate for both monochorionic and dichorionic twins in providing accurate first trimester risks for trisomy 21. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 10 references indexed in Scilit:
- One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimesterBJOG: An International Journal of Obstetrics and Gynaecology, 2000
- Early prediction of severe twin-to-twin transfusion syndromeHuman Reproduction, 2000
- First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucencyObstetrics & Gynecology, 2000
- First trimester prenatal diagnosis of trisomy 21 in discordant twins using fetal nuchal translucency thickness and maternal serum free ?-hCG and PAPP-APrenatal Diagnosis, 2000
- Screening for trisomy 21 in twin pregnancies in the first trimester using free ?-hCG and PAPP-A, combined with fetal nuchal translucency thicknessPrenatal Diagnosis, 2000
- Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucencyPrenatal Diagnosis, 1999
- First-trimester screening for Down syndrome using nuchal translucency measurement with free β-hCG and PAPP-A between 10 and 13 weeks of pregnancy—the combined testPrenatal Diagnosis, 1999
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 1999
- Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestationBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Anomalous Development of TwinsPublished by Springer Nature ,1994